During Wednesday’s Current trade, Shares of NTELOS Holdings Corp (NASDAQ:NTLS), lost -0.27% to $9.15.
NTELOS Holdings Corp. (NTLS) declared operating and financial results for its second quarter ended June 30, 2015. In the fourth quarter of 2014, the Company declared a planned refocus of its business operations in its western Virginia and West Virginia markets (“Western Markets” or “Markets”). The Company is presently in the process of winding down operations in its Eastern Markets, which it anticipates to complete by November 15, 2015.
Highlights
- Revenues raised 6% to $91.4 million for the second quarter 2015, contrast to $86.1 million for the second quarter 2014;
- Postpaid average monthly billings per user (“ABPU”) was $58.64 for the second quarter 2015, contrast to $58.04 for the first quarter 2015 and $59.78 for the second quarter 2014;
- Adjusted EBITDA was $27.5 million for the second quarter 2015, contrast to $33.3 million for the second quarter 2014. Adjusted EBITDA during the second quarter 2015 reflected the absorption of corporate overhead formerly allocated to the Eastern Markets in 2014;
- Net subscriber additions for the six months ended June 30, 2015 of 15,400 exceeded net subscriber additions for the full year 2014 of 14,600;
NTELOS Holdings Corp., through its auxiliaries, provides digital wireless communications services. The company offers wireless voice and digital data personal communication products and services primarily to retail and business customers under the NTELOS Wireless and FRAWG Wireless brands. It provides postpay and prepay services; network access, data services, feature services, and equipment services; and an interactive Web presence, which offers customers with access to their account, auto-pay billing service, and account monitoring services, such as overage text alerts and other customer care support.
Shares of Capnia Inc (NASDAQ:CAPN), declined -6.08% to $2.47, during its current trading session.
Capnia, Inc. (CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for precision metering of gas flow, declared financial results for the second quarter ended June 30, 2015.
Recent Developments and Forthcoming Milestones
CoSense
Executing CoSense Commercial Rollout — During the second quarter, Capnia strengthened its commercial sales team with the appointment of Chief Commercial Officer, Edward Ebbers. This neonatology-focused team is targeting 400 of the top U.S. hospitals based on number of newborn births each year, with the aim of maximizing initial sales of the CoSense device and rapidly growing recurring revenues from sales of per-test consumables. The commercial sales team has profiled and identified key accounts nationwide and the Company is in talk aboutions with several healthcare institutions.
Developing Sickle Cell Disease (SCD) Screening in Developing Countries — In April, Capnia declared it was awarded a Small Business Innovation Research (SBIR) Phase I grant for $220,000 by the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH). This grant will be used to assist fund the development of a modified CoSense device that is suitable for field use in developing countries with high prevalence of SCD.
Capnia, Inc. develops diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow primarily in the United States. The company offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition that causes long-term developmental disability due to the degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has accomplished phase II clinical trials for the treatment of symptoms related to allergic rhinitis.
Guess?, Inc. (NYSE:GES), during its Wednesday’s current trading session decreased -2.29% to $20.87.
Guess?, Inc. (GES) will release its financial results for the second quarter of fiscal 2016, which ended August 1, 2015, on Wednesday, August 26, 2015. The Company will webcast a conference call at 4:30 p.m. (ET) that day to talk about the results.
Guess?, Inc. designs, markets, distributes, and licenses lifestyle collections of contemporary apparel and accessories for men, women, and children that reflect the American lifestyle and European fashion sensibilities. It operates through North American Retail, Europe, Asia, North American Wholesale, and Licensing segments. The company’s clothing collection comprises jeans, pants, skirts, dresses, shorts, blouses, shirts, jackets, knitwear, and intimate apparel. It also grants licenses to manufacture and distribute various products that complement its apparel lines, such as eyewear, watches, handbags, footwear, kids and infants apparel, outerwear, swimwear, fragrance, jewelry, and other fashion accessories.
Finally, Westlake Chemical Corporation (NYSE:WLK), decreased -1.96%, to $57.46.
Westlake Chemical Corporation (WLK) stated record net income for the second quarter of 2015 of $205.1 million, or $1.54 per diluted share, on net sales of $1,185.0 million. This represents an enhance in net income attributable to Westlake Chemical Corporation of $35.7 million, or $0.28 per diluted share, contrast to the quarter ended June 30, 2014 net income of $169.4 million, or $1.26 per diluted share, on net sales of $998.6 million. Net income for the second quarter of 2015 comprised of a net pre-tax gain of $15.5 million, or $0.13 per diluted share, related to a gain from the acquisition of a controlling interest in Suzhou Huasu Plastics Co., Ltd. (“Huasu”), a Chinese PVC joint venture, and an impairment loss related to an equity investment. The gain from the acquisition was non-taxable and resulted in the lowering of our effective tax rate for the second quarter of 2015 from about 34.3% to 31.9%. Net sales for the second quarter of 2015 raised by $186.4 million contrast to net sales for the second quarter of 2014, mainly attributable to sales contributed by Vinnolit, our specialty PVC resin business, which we attained in July 2014, and higher sales volumes for most of our major products, partially offset by lower sales prices for all our major products. Income from operations was $295.4 million for the second quarter of 2015 as contrast to $266.8 million for the second quarter of 2014. Income from operations for the second quarter of 2015 benefited from improved vinyls integrated product margins as a result of lower feedstock costs, raised production at our Calvert City, Kentucky facility following the completion of the ethylene expansion project, higher production rates at our Geismar, Louisiana chlor-alkali plant, and the contribution from Vinnolit as contrast to the second quarter of 2014. However, this benefit was partially offset by lower olefins integrated product margins as a result of lower sales prices in the second quarter of 2015 as contrast to the preceding-year period, and costs related to several maintenance turnarounds accomplished during the second quarter of 2015.
Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and fabricated building products. It operates through two segments, Olefins and Vinyls. The Olefins segment offers ethylene, polyethylene, styrene monomer, and various ethylene co-products, such as chemical grade propylene, crude butadiene, pyrolysis gasoline, and hydrogen.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
